Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

The efficacy of Covid-19 vaccine in hematopoietic stem cell transplantation (HSCT) recipients is still unknown. We planned a prospective study to evaluate the immune response after the administration of Covid-19 vaccine in HSCT recipients. Fifty patients previously submitted to HSCT (38 autologous a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarucci, Martina, Paolasini, Sara, Isidori, Alessandro, Guiducci, Barbara, Loscocco, Federica, Capalbo, Maria, Visani, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451475/
https://www.ncbi.nlm.nih.gov/pubmed/34552880
http://dx.doi.org/10.3389/fonc.2021.737300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451475/
https://www.ncbi.nlm.nih.gov/pubmed/34552880
http://dx.doi.org/10.3389/fonc.2021.737300

Ejemplares similares